GLYC
Glycomimetics Inc · HEALTHCARE
Invus Public Equities, L.P. bought $3.0M of Glycomimetics Inc
10% owner
Bought$3,027,929
$2.00Price
1,515,266Shares
+23%Stake
What GLYC did for a copier
- $1,000 copied at Fri, Feb 17 close, $188.00
- $665
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Apr 3 close.
Invus Public Equities, L.P.'s record
4 other buys with 3 months of prices since 2017: on average −18.0% against the S&P 500, and 1 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Feb 15. Filed Fri, Feb 17, 12:29 PM ET, during the session. Returns use the Feb 17 close and the Apr 3 close. Not investment advice.